Guanxiong Ding
Fudan University(CN)Huashan Hospital(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Renal and related cancers, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer(2015)79 cited
- → Diabetes mellitus and prostate cancer risk of different grade or stage: A systematic review and meta-analysis(2013)70 cited
- → HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer(2019)47 cited
- → PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways(2015)44 cited
- → Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer(2013)41 cited
- → LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway(2018)40 cited
- → EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis(2018)39 cited
- → Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition(2013)36 cited
- → HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer(2020)35 cited
- → Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2(2012)32 cited